Formulation and Evaluation of Different Nanogels of Tapinarof for Treatment of Psoriasis

Psoriasis is an immune-mediated skin condition. There are many therapeutic options for its treatment; however, none of them is completely effective. Tapinarof is a promising new active substance; it was recently approved by the FDA for the treatment of psoriasis. The aim of our study was to prepare...

Full description

Saved in:
Bibliographic Details
Main Authors: Barbara Balogh, Ágota Pető, Ádám Haimhoffer, Dávid Sinka, Dóra Kósa, Pálma Fehér, Zoltán Ujhelyi, Monica Argenziano, Roberta Cavalli, Ildikó Bácskay
Format: Article
Language:English
Published: MDPI AG 2024-10-01
Series:Gels
Subjects:
Online Access:https://www.mdpi.com/2310-2861/10/11/675
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850267631976710144
author Barbara Balogh
Ágota Pető
Ádám Haimhoffer
Dávid Sinka
Dóra Kósa
Pálma Fehér
Zoltán Ujhelyi
Monica Argenziano
Roberta Cavalli
Ildikó Bácskay
author_facet Barbara Balogh
Ágota Pető
Ádám Haimhoffer
Dávid Sinka
Dóra Kósa
Pálma Fehér
Zoltán Ujhelyi
Monica Argenziano
Roberta Cavalli
Ildikó Bácskay
author_sort Barbara Balogh
collection DOAJ
description Psoriasis is an immune-mediated skin condition. There are many therapeutic options for its treatment; however, none of them is completely effective. Tapinarof is a promising new active substance; it was recently approved by the FDA for the treatment of psoriasis. The aim of our study was to prepare topical nanoformulations of the active substance to improve its bioavailability and therapeutic effect. The biocompatibility investigation of the formulations was carried out by MTT assay, and the size distribution of the preparations was investigated by DLS. In parallel, the rheological properties and the texture were examined, and the in vitro release of tapinarof was assessed by the Franz diffusion method. An in vitro wound healing assay was also carried out to study the drug’s properties. Our results show that the preparations were safe on HaCaT cells. The particle size of the formulations was proven to be in the nanoscale range. In the in vitro release studies, nanogel II. showed greater release of the active substance. According to the wound healing assay, incorporation of the drug into nanoformulations increases the antiproliferative and antimigration activity of the drug. Overall, nanoformulations of tapinarof were successfully prepared, and our results suggest that they can be a useful addition to the current therapeutic practice of psoriasis.
format Article
id doaj-art-6e0529bc7ace429985dddbff2562f685
institution OA Journals
issn 2310-2861
language English
publishDate 2024-10-01
publisher MDPI AG
record_format Article
series Gels
spelling doaj-art-6e0529bc7ace429985dddbff2562f6852025-08-20T01:53:44ZengMDPI AGGels2310-28612024-10-01101167510.3390/gels10110675Formulation and Evaluation of Different Nanogels of Tapinarof for Treatment of PsoriasisBarbara Balogh0Ágota Pető1Ádám Haimhoffer2Dávid Sinka3Dóra Kósa4Pálma Fehér5Zoltán Ujhelyi6Monica Argenziano7Roberta Cavalli8Ildikó Bácskay9Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Nagyerdei Körút 98, H-4032 Debrecen, HungaryDepartment of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Nagyerdei Körút 98, H-4032 Debrecen, HungaryDepartment of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Nagyerdei Körút 98, H-4032 Debrecen, HungaryDepartment of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Nagyerdei Körút 98, H-4032 Debrecen, HungaryDepartment of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Nagyerdei Körút 98, H-4032 Debrecen, HungaryDepartment of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Nagyerdei Körút 98, H-4032 Debrecen, HungaryDepartment of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Nagyerdei Körút 98, H-4032 Debrecen, HungaryDepartment of Drug Science and Technology, University of Turin, Via P. Giuria 9, 10125 Turin, ItalyDepartment of Drug Science and Technology, University of Turin, Via P. Giuria 9, 10125 Turin, ItalyDepartment of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Nagyerdei Körút 98, H-4032 Debrecen, HungaryPsoriasis is an immune-mediated skin condition. There are many therapeutic options for its treatment; however, none of them is completely effective. Tapinarof is a promising new active substance; it was recently approved by the FDA for the treatment of psoriasis. The aim of our study was to prepare topical nanoformulations of the active substance to improve its bioavailability and therapeutic effect. The biocompatibility investigation of the formulations was carried out by MTT assay, and the size distribution of the preparations was investigated by DLS. In parallel, the rheological properties and the texture were examined, and the in vitro release of tapinarof was assessed by the Franz diffusion method. An in vitro wound healing assay was also carried out to study the drug’s properties. Our results show that the preparations were safe on HaCaT cells. The particle size of the formulations was proven to be in the nanoscale range. In the in vitro release studies, nanogel II. showed greater release of the active substance. According to the wound healing assay, incorporation of the drug into nanoformulations increases the antiproliferative and antimigration activity of the drug. Overall, nanoformulations of tapinarof were successfully prepared, and our results suggest that they can be a useful addition to the current therapeutic practice of psoriasis.https://www.mdpi.com/2310-2861/10/11/675tapinarofnanogelspsoriasisSNEDDSwound healing
spellingShingle Barbara Balogh
Ágota Pető
Ádám Haimhoffer
Dávid Sinka
Dóra Kósa
Pálma Fehér
Zoltán Ujhelyi
Monica Argenziano
Roberta Cavalli
Ildikó Bácskay
Formulation and Evaluation of Different Nanogels of Tapinarof for Treatment of Psoriasis
Gels
tapinarof
nanogels
psoriasis
SNEDDS
wound healing
title Formulation and Evaluation of Different Nanogels of Tapinarof for Treatment of Psoriasis
title_full Formulation and Evaluation of Different Nanogels of Tapinarof for Treatment of Psoriasis
title_fullStr Formulation and Evaluation of Different Nanogels of Tapinarof for Treatment of Psoriasis
title_full_unstemmed Formulation and Evaluation of Different Nanogels of Tapinarof for Treatment of Psoriasis
title_short Formulation and Evaluation of Different Nanogels of Tapinarof for Treatment of Psoriasis
title_sort formulation and evaluation of different nanogels of tapinarof for treatment of psoriasis
topic tapinarof
nanogels
psoriasis
SNEDDS
wound healing
url https://www.mdpi.com/2310-2861/10/11/675
work_keys_str_mv AT barbarabalogh formulationandevaluationofdifferentnanogelsoftapinaroffortreatmentofpsoriasis
AT agotapeto formulationandevaluationofdifferentnanogelsoftapinaroffortreatmentofpsoriasis
AT adamhaimhoffer formulationandevaluationofdifferentnanogelsoftapinaroffortreatmentofpsoriasis
AT davidsinka formulationandevaluationofdifferentnanogelsoftapinaroffortreatmentofpsoriasis
AT dorakosa formulationandevaluationofdifferentnanogelsoftapinaroffortreatmentofpsoriasis
AT palmafeher formulationandevaluationofdifferentnanogelsoftapinaroffortreatmentofpsoriasis
AT zoltanujhelyi formulationandevaluationofdifferentnanogelsoftapinaroffortreatmentofpsoriasis
AT monicaargenziano formulationandevaluationofdifferentnanogelsoftapinaroffortreatmentofpsoriasis
AT robertacavalli formulationandevaluationofdifferentnanogelsoftapinaroffortreatmentofpsoriasis
AT ildikobacskay formulationandevaluationofdifferentnanogelsoftapinaroffortreatmentofpsoriasis